Pharma Tips

Lupin reports 26% rise in Q3 net profit

By: Pharma Tips | Views: 694 | Date: 03-Feb-2015

Drug firm Lupin on Tuesday reported a 26.32 per cent rise in its consolidated net profit at Rs 601.45 crore for the quarter ended December 2014 on account of robust sales and improved operational efficiencies.


Lupin reports 26% rise in Q3 net profit

Drug firm Lupin on Tuesday reported a 26.32 per cent rise in its consolidated net profit at Rs 601.45 crore for the quarter ended December 2014 on account of robust sales and improved operational efficiencies.

The company had posted a net profit of Rs 476.13 crore in the same period of previous fiscal. Net sales of the company rose to Rs 3,144.91 crore for quarter under review as compared to Rs 2,982.97 crore in the same period of previous fiscal.

The company's continued focus on improving operational efficiencies has led to sustained margins and profit growth notwithstanding regulatory delays that have resulted in pressures on the topline, Lupin Ltd Managing Director Nilesh Gupta said in a statement.

The performance for the three quarters taken as a whole is more representative of the growth enjoyed by the company, he added.

The Mumbai-based company said its US and Europe formulation sales grew by four per cent to Rs 1,484.8 crore during the third quarter as against Rs 1,422.8 crore in the same period of previous fiscal, contributing 47 per cent to overall sales.

The company's India formulations business grew by 14 per cent during the quarter, posting net sales of Rs 743.8 crore as compared to Rs 650.4 crore in the same period of previous financial year.

Lupin's Japan sales declined by eight per cent, clocking net sales of Rs 342.2 crore during the third quarter as against Rs 372 crore in the same period of previous fiscal.

The company said its active pharmaceutical ingredients (API) business posted sales of Rs 275.8 crore during the quarter as compared to Rs 297.3 crore in October-December period of 2013-14.
Previous Page Next Page

People Searching On This Page:

Related Pages


Cipla posts 15 percent rise in Q3 profit

Cipla posts 15 percent rise in Q3 profit

News | Pharma Companies
Date:
26-Feb-2015  Views: 1863

Cipla, the pharmaceutical firm, on Thursday reported 15.31 per cent increase in its consolidated net profit at Rs 327.85 crore in the third quarter e ...
Biocon net profit falls 13% to Rs 91 cr; to offload 10-15% in Syngene

Biocon net profit falls 13% to Rs 91 cr; to offload 10-15% in Syngene

News | Pharma Companies
Date:
11-Feb-2015  Views: 778

Biotech firm Biocon on Thursday reported a 13 per cent fall in net profit for October-December quarter at Rs 91 crore and said it will sell 10-15 per ...
Wockhardt net profit rises 14.05% in Q3

Wockhardt net profit rises 14.05% in Q3

News | Pharma Companies
Date:
10-Feb-2015  Views: 789

Pharmaceuticals firm Wockhardt on Wednesday reported a 14.05 per cent rise in consolidated net profit at Rs 347.25 crore for the third quarter ended D ...
Dr Reddy's net profit falls 7.09% in Q3

Dr Reddy's net profit falls 7.09% in Q3

News | Pharma Companies
Date:
05-Feb-2015  Views: 705

Drug major Dr Reddy's Laboratories on Thursday reported a 7.09 per cent decline in its consolidated net profit at Rs 574.53 crore for the quarter ende ...
Sun Pharma Q4 net profit up 57 percent, beats expectations

Sun Pharma Q4 net profit up 57 percent, beats expectations

News | Pharma Companies
Date:
22-Jul-2014  Views: 1333

Sun Pharmaceutical Industries, India's third-largest drugmaker by revenue, has reported a 57 per cent jump in fourth-quarter net profit, slightly abov ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

15  + 9 =     
Comments

Google : 71 times | Yahoo : 11 times | Bing : 5 times |